These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 16266693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
    Newby AC.
    Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
    [Abstract] [Full Text] [Related]

  • 3. Implication of adenylyl cyclase 8 in pathological smooth muscle cell migration occurring in rat and human vascular remodelling.
    Gueguen M, Keuylian Z, Mateo V, Mougenot N, Lompré AM, Michel JB, Meilhac O, Lipskaia L, Limon I.
    J Pathol; 2010 Jul; 221(3):331-42. PubMed ID: 20527026
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms in intimal hyperplasia.
    Newby AC, Zaltsman AB.
    J Pathol; 2000 Feb; 190(3):300-9. PubMed ID: 10685064
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL.
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
    Rudijanto A.
    Acta Med Indones; 2007 Mar; 39(2):86-93. PubMed ID: 17933075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Do metalloproteinases destabilize vulnerable atherosclerotic plaques?
    Newby AC.
    Curr Opin Lipidol; 2006 Oct; 17(5):556-61. PubMed ID: 16960505
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
    Liu Y, Dolence J, Ren J, Rao M, Sreejayan N.
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
    [Abstract] [Full Text] [Related]

  • 15. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.
    Newby AC, Zaltsman AB.
    Cardiovasc Res; 1999 Feb; 41(2):345-60. PubMed ID: 10341834
    [Abstract] [Full Text] [Related]

  • 16. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.
    Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ.
    J Pathol; 2003 Jul; 200(4):516-25. PubMed ID: 12845619
    [Abstract] [Full Text] [Related]

  • 17. The molecular biology of furin-like proprotein convertases in vascular remodelling.
    Stawowy P, Kappert K.
    Methods Mol Biol; 2011 Jul; 768():191-206. PubMed ID: 21805243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.